The primary outcome measures will be crestal bone loss at the mesial and distal aspects of each implant. The secondary outcomes will be the presence or absence of peri-implant radiolucency, patient's pain experience (intensity (VAS) and number of analgesics taken), surgeon's perception of healing (intensity of swelling and presence/absence of bruising, pus exudate and wound dehiscence), PICF levels of MMP-8, sRANKL, and OPG, modified PI, presence or absence of implant mobility, presence or absence of pain, infection, neuropathies, and pus exudate.